These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3471523)

  • 21. Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma.
    Martino S; Decker DA; Hynes HE; Kresge CL
    Invest New Drugs; 1987 Dec; 5(4):373-4. PubMed ID: 3481362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aclarubicin-associated QTc prolongation and ventricular fibrillation.
    Iwata N; Karasawa M; Omine M; Maekawa T; Suzuki T; Kawai Y
    Cancer Treat Rep; 1984 Mar; 68(3):527-9. PubMed ID: 6584207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.
    Schütte J; Niederle N; Seeber S
    J Cancer Res Clin Oncol; 1983; 105(2):162-5. PubMed ID: 6572190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
    Kish JA; Al-Sarraf M
    Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
    Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
    Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
    [No Abstract]   [Full Text] [Related]  

  • 30. Aclacinomycin A, a new anti-leukaemic agent.
    Suzuki H; Kawashima K; Yamada K
    Lancet; 1979 Apr; 1(8121):870-1. PubMed ID: 86110
    [No Abstract]   [Full Text] [Related]  

  • 31. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies of aclacinomycin A (ACM).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):234-6. PubMed ID: 3473923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aclacinomycin A.
    Oka S; Mathé G; Mitrou PS
    Cancer Treat Rev; 1984 Dec; 11(4):299-302. PubMed ID: 6598408
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical review of aclacinomycin A in Japan.
    Ota K
    Drugs Exp Clin Res; 1985; 11(1):17-21. PubMed ID: 3869800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck.
    Eckenrode JL; Wheeler RH; Forastiere AA
    Invest New Drugs; 1985; 3(4):389-92. PubMed ID: 3866756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aclarubicin-related pancreatitis in a child with AML].
    Adachi S; Akiyama Y; Takimoto T; Tanizawa A; Kiriyama Y; Kubota Y; Mikawa H
    Rinsho Ketsueki; 1988 Mar; 29(3):385-8. PubMed ID: 3165144
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
    Warrell RP
    Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.